Hemodynamic parameters in hypertensive diabetic patients

Journal of Hypertension

Volumn 34, Issue 6, 2016, Pages 1123-1131

  Yannoutsos, Alexandra ^a   Ahouah, Mathieu ^a   Tubiana, Céline Dreyfuss ^a   Topouchian, Jirar ^a   Touboul, Caroline ^a   Safar, Michel E ^a   Blacher, Jacques ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

aortic stiffness; diabetes; hypertension; pulse pressure amplification; pulse wave velocity

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; ORAL ANTIDIABETIC AGENT; THIAZIDE DIURETIC AGENT; ANTIHYPERTENSIVE AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE; APPLANATION TONOMETRY; ARTERIAL STIFFNESS; ARTICLE; BODY HEIGHT; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; GENDER; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; TONOMETRY; AGED; BLOOD PRESSURE; COMPLICATION; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84961390078     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000898     Document Type: Article

References (29)

1. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321:412-419.
2. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358:2545-2559.
3. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33:1111-1117.
4. Ben-ShlomoY, Spears M,Boustred C,May M,Anderson SG, Benjamin EJ, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participantmeta-analysis of prospective observational data from 17 635 subjects. J AmColl Cardiol 2014; 63:636-646.
5. Benetos A, Thomas F, Joly L. Pulse pressure amplification: a mechanical biomarker of cardiovascular risk. J AmColl Cardiol 2010; 55:1032-1307.
6. Safar ME, London GM, Asmar R, Frohlich ED. Third workshop on structure and function of large arteries: part I. Recent advances on large arteries in hypertension. Hypertension 1998; 32:156-161.
7. McEniery CM, Yasmin. McDonnell B, Munnery M, Wallace SM, Rowe CV, et al. Central pressure: variability and impact of cardiovascular risk factors. The anglo-cardiff collaborative trial II. Hypertension 2008; 51:1476-1482.
8. Reference Values for Arterial Stiffness Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: establishing normal and reference values. Eur Heart J 2010; 31:2338-2350.
9. Tedesco MA, Natale F, Di Salvo G, Caputo S, Capasso M, Calabro R. Effects of coexisting hypertension and type 2 diabetes mellitus on arterial stiffness. J Human Hypertens 2004; 18:469-473.
10. Protogerou AD, Blacher J, Mavrikakis M, Lekakis J, Safar ME. Increased pulse pressure amplification in treated hypertensive subjects with metabolic syndrome. Am J Hypertens 2007; 20:127-133.
11. Cardoso CR, Ferreira MT, Leite NC, Salles GF. Prognostic impact of aortic stiffness in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study. Diabetes Care 2013; 36:3772-3778.
12. Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S. Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension 1997; 30:1267-1273.
13. Boutouyrie P, Lacolley P, Briet M, Regnault V, Stanton A, Laurent S, Mahmud A. Pharmacological modulation of arterial stiffness. Drugs 2011; 71:1689-1701.
14. Protogerou AD, Stergiou GS, Vlachopoulos C, Blacher J, Achimastos A. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: evidence for specific class-effects of antihypertensive drugs on pressure amplification. Curr Pharm Des 2009; 15:272-289.
15. Safar ME, Balkau B, Lange C, Protogerou AD, Czernichow S, Blacher J, et al. Hypertension and vascular dynamics in men and women with metabolic syndrome. J Am Coll Cardiol 2013; 61:12-19.
16. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 1995; 26:485-490.
17. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation 1997; 95:1827-1836.
18. Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 2009; 54:1328-1336.
19. Agnoletti D, Lieber A, Zhang Y, Protogerou AD, Borghi C, Blacher J, Safar ME. Central hemodynamic modifications in diabetes mellitus. Atherosclerosis 2013; 230:315-321.
20. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008; 51:527-539.
21. Najjar SS, Scuteri A, Shetty V, Wright JG, Muller DC, Fleg JL, et al. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol 2008; 51:1377-1383.
22. Muiesan ML, Salvetti M, Rizzoni D, Paini A, Agabiti-Rosei C, Aggiusti C, et al. Pulsatile hemodynamics and microcirculation: evidence for a close relationship in hypertensive patients. Hypertension 2013; 61: 130-136.
23. Vergnaud AC, Protogerou AD, Li Y, Czernichow S, Vesin C, Blacher J, Safar ME. Pulse pressure amplification, adiposity and metabolic syndrome in subjects under chronic antihypertensive therapy: the role of heart rate. Atherosclerosis 2008; 199:222-229.
24. Albaladejo P, Copie X, Boutouyrie P, Laloux B, Declere AD, Smulyan H, Benetos A. Heart rate, arterial stiffness, and wave reflections in paced patients. Hypertension 2001; 38:949-952.
25. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007; 115:387-397.
26. Regnault V, Thomas F, Safar ME, Osborne-Pellegrin M, Khalil RA, Pannier B, Lacolley P. Sex difference in cardiovascular risk: role of pulse pressure amplification. J Am Coll Cardiol 2012; 59:1771-1777.
27. Devereux RB, Bang CN, Roman MJ, Palmieri V, Boman K, Gerdts E, et al. Left ventricular wall stress-mass-heart rate product and cardiovascular events in treated hypertensive patients: LIFE Study. Hypertension 2015; 66:945-953.
28. Raison J, Rudnichi A, Safar ME. Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study. J Hum Hypertens 2002; 16:705-710.
29. Safar ME, Protogerou AD, Blacher J. Statins, central blood pressure, and blood pressure amplification. Circulation 2009; 119:9-12.